Home

Becton Dickinson (BDX)

249.07
+0.58 (0.23%)

Becton Dickinson is a global medical technology company that specializes in the development and manufacture of medical devices, instrument systems, and reagents

The company focuses on improving patient care and advancing healthcare delivery through its diverse product offerings, which include syringes, needles, blood collection systems, and diagnostic tools. With a strong commitment to innovation and quality, Becton Dickinson serves healthcare professionals and institutions around the world, facilitating safe and effective medical procedures and enhancing the overall health and well-being of patients.

SummaryNewsPress ReleasesChartHistoricalFAQ
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
BD (Becton, Dickinson and Company) (NYSEBDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.
By Biosero, Inc. · Via Business Wire · January 23, 2025
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Carl Hull to Retire as Executive Chairman
By Maravai LifeSciences Holdings LLC · Via GlobeNewswire · December 5, 2024
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024
Via MarketBeat · May 4, 2024
Becton Dickinson and Company (NYSE: BDX) is a Leading Gainer in Monday Morning Trading
Becton, Dickinson And Company (NYSEBDX) is one of today’s top gainers. The company’s shares are currently up 6.3% on the day to $281.53.
Via Investor Brand Network · July 24, 2023
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Via MarketBeat · April 30, 2024
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028
EQNX::TICKER_START (NASDAQSTSS),NYSE:STVNNYSESTVN)(NYSE:WSTNYSEWST,(NYSE:BDXNYSE),(NYSE:PFEPFE) EQNX::TICKER_END
Via FinancialNewsMedia · September 26, 2023
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning
Via MarketBeat · May 30, 2023
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield.
Via MarketBeat · March 14, 2023
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
By David Willey, Benzinga
Via TheNewswire.com · March 1, 2023
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Lucira Health Inc. (NASDAQLHDX) shares spiked up 264% to close at $0.52 on a massive 278 million shares traded on the announcement of FDA approval for its
Via MarketBeat · March 1, 2023
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
By David Willey, Benzinga
Via TheNewswire.com · January 17, 2023
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029
EQNX::TICKER_START (NASDAQSTSS),NYSE:BDXNYSEBDX)(NYSE:CAHNYSECAH,(NYSE:NVONYSE),(OTCPK:TRUMY),(NASDAQ:STSSWSTSSW) EQNX::TICKER_END
Via FinancialNewsMedia · January 12, 2023
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSEEW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
Via MarketBeat · November 7, 2022
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQISRG) is turning 22 years old since its U.S. Food and Drug
Via MarketBeat · November 1, 2022
BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
Regulatory News:
By BIOCORP · Via Business Wire · October 18, 2022
3 Defensive Stocks With 60-Year Dividend Hike Streaks
With the U.S. economy staring at another recession, it may be a good time to lean on the stability and income of the dividend growth champs.
Via MarketBeat · September 21, 2022
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
FN Media Group Presents USA News Group News Commentary   Vancouver, BC –November 9, 2021 – USA News Group  –  New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up authorization, especially in the wake of a shortage. A study from Kaiser […]
Via FinancialNewsMedia · November 9, 2021
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
FN Media Group Presents USA News Group News Commentary   Vancouver, BC –October 20, 2021 – USA News Group  –  It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction, better known as the PCR test, to detect Covid-19. Mass testing is becoming […]
Via FinancialNewsMedia · October 20, 2021
Big Changes Coming to Covid Testing in Response to Rising Demand Under Latest Mandates
FN Media Group Presents USA News Group News Commentary
Via FinancialNewsMedia · September 28, 2021